microRNA information: hsa-miR-331-5p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-331-5p | miRbase |
| Accession: | MIMAT0004700 | miRbase |
| Precursor name: | hsa-mir-331 | miRbase |
| Precursor accession: | MI0000812 | miRbase |
| Symbol: | MIR331 | HGNC |
| RefSeq ID: | NR_029895 | GenBank |
| Sequence: | CUAGGUAUGGUCCCAGGGAUCC |
Reported expression in cancers: hsa-miR-331-5p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-331-5p | acute myeloid leukemia | deregulation | "Expression of microRNA 331 can be used as a predic ......" | 25620533 | Reverse transcription PCR |
Reported cancer pathway affected by hsa-miR-331-5p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-331-5p | colorectal cancer | Apoptosis pathway | "MiR 331 3p inhibits proliferation and promotes apo ......" | 26718987 |
Reported cancer prognosis affected by hsa-miR-331-5p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-331-5p | acute myeloid leukemia | poor survival; drug resistance | "Expression of microRNA 331 can be used as a predic ......" | 25620533 | |
| hsa-miR-331-5p | liver cancer | metastasis | "MicroRNA 331 3p promotes proliferation and metasta ......" | 24825302 |
Reported gene related to hsa-miR-331-5p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-331-5p | prostate cancer | EGFR | "The RNA binding protein HuR opposes the repression ......" | 21971048 |
| hsa-miR-331-5p | prostate cancer | EGFR | "miR 331 3p regulates ERBB 2 expression and androge ......" | 19584056 |
| hsa-miR-331-5p | colorectal cancer | ERBB2 | "MiR 331 3p inhibits proliferation and promotes apo ......" | 26718987 |
| hsa-miR-331-5p | gastric cancer | ERBB2 | "Lnc RNA HOTAIR functions as a competing endogenous ......" | 24775712 |
| hsa-miR-331-5p | cervical and endocervical cancer | NRP2 | "MicroRNA 331 3p Suppresses Cervical Cancer Cell Pr ......" | 27548144 |
| hsa-miR-331-5p | glioblastoma | NRP2 | "miR 331 3p regulates expression of neuropilin 2 in ......" | 24142150 |
| hsa-miR-331-5p | prostate cancer | AR | "miR 331 3p regulates ERBB 2 expression and androge ......" | 19584056 |
| hsa-miR-331-5p | prostate cancer | ELAVL1 | "The RNA binding protein HuR opposes the repression ......" | 21971048 |
| hsa-miR-331-5p | gastric cancer | HOTAIR | "Lnc RNA HOTAIR functions as a competing endogenous ......" | 24775712 |
| hsa-miR-331-5p | liver cancer | ING5 | "Upregulated in Hepatitis B virus associated hepato ......" | 26497554 |
| hsa-miR-331-5p | liver cancer | RLTPR | "MicroRNA 331 3p promotes proliferation and metasta ......" | 24825302 |
| hsa-miR-331-5p | prostate cancer | SDC1 | "Syndecan 1 up regulates microRNA 331 3p and mediat ......" | 26259043 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-331-5p | PKIG | 9 cancers: BLCA; COAD; ESCA; HNSC; LIHC; LUSC; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.512; TCGA COAD -0.177; TCGA ESCA -0.153; TCGA HNSC -0.293; TCGA LIHC -0.125; TCGA LUSC -0.392; TCGA SARC -0.156; TCGA STAD -0.464; TCGA UCEC -0.258 |
hsa-miR-331-5p | TNRC6C | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.213; TCGA BRCA -0.068; TCGA CESC -0.155; TCGA COAD -0.16; TCGA ESCA -0.169; TCGA KIRC -0.077; TCGA KIRP -0.092; TCGA LGG -0.072; TCGA LIHC -0.085; TCGA LUAD -0.093; TCGA STAD -0.319; TCGA UCEC -0.108 |
hsa-miR-331-5p | RAI2 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget; PITA; miRNATAP | TCGA BLCA -0.781; TCGA BRCA -0.448; TCGA CESC -0.69; TCGA COAD -0.434; TCGA ESCA -0.561; TCGA HNSC -0.641; TCGA KIRC -0.182; TCGA LUAD -0.373; TCGA LUSC -0.642; TCGA PRAD -0.073; TCGA THCA -0.301; TCGA STAD -0.718; TCGA UCEC -0.361 |
hsa-miR-331-5p | DCAF8 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; PAAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.092; TCGA CESC -0.12; TCGA COAD -0.065; TCGA ESCA -0.145; TCGA HNSC -0.086; TCGA KIRC -0.063; TCGA KIRP -0.053; TCGA LIHC -0.208; TCGA LUAD -0.066; TCGA OV -0.066; TCGA PAAD -0.096; TCGA SARC -0.115; TCGA STAD -0.142; TCGA UCEC -0.116 |
hsa-miR-331-5p | REEP1 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.86; TCGA BRCA -0.306; TCGA CESC -0.381; TCGA COAD -0.822; TCGA ESCA -0.474; TCGA KIRC -0.178; TCGA LUAD -0.299; TCGA LUSC -0.386; TCGA SARC -0.405; TCGA STAD -0.985; TCGA UCEC -0.436 |
hsa-miR-331-5p | CCL21 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUSC; PAAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -1.443; TCGA BRCA -0.835; TCGA COAD -1.228; TCGA ESCA -0.581; TCGA HNSC -0.308; TCGA LUSC -0.64; TCGA PAAD -0.836; TCGA STAD -0.667; TCGA UCEC -0.937 |
hsa-miR-331-5p | NAALADL2 | 9 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; THCA; STAD | MirTarget | TCGA BLCA -0.264; TCGA BRCA -0.171; TCGA CESC -0.512; TCGA COAD -0.277; TCGA HNSC -0.535; TCGA KIRC -0.516; TCGA KIRP -0.311; TCGA THCA -0.118; TCGA STAD -0.175 |
hsa-miR-331-5p | SRGN | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.372; TCGA BRCA -0.077; TCGA COAD -0.229; TCGA ESCA -0.244; TCGA HNSC -0.191; TCGA LUAD -0.235; TCGA LUSC -0.577; TCGA PAAD -0.353; TCGA UCEC -0.136 |
hsa-miR-331-5p | CDH5 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget; PITA | TCGA BLCA -0.397; TCGA BRCA -0.313; TCGA CESC -0.357; TCGA COAD -0.338; TCGA ESCA -0.201; TCGA HNSC -0.302; TCGA LIHC -0.222; TCGA LUAD -0.236; TCGA LUSC -0.644; TCGA OV -0.092; TCGA PAAD -0.186; TCGA STAD -0.176; TCGA UCEC -0.299 |
hsa-miR-331-5p | ANGPTL2 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUSC; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA BLCA -0.657; TCGA BRCA -0.349; TCGA CESC -0.197; TCGA COAD -0.526; TCGA HNSC -0.351; TCGA LGG -0.524; TCGA LUSC -0.44; TCGA PAAD -0.269; TCGA PRAD -0.109; TCGA STAD -0.404; TCGA UCEC -0.271 |
hsa-miR-331-5p | UBL3 | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; STAD; UCEC | MirTarget; PITA; miRNATAP | TCGA BLCA -0.217; TCGA BRCA -0.086; TCGA CESC -0.315; TCGA COAD -0.151; TCGA ESCA -0.461; TCGA HNSC -0.319; TCGA KIRC -0.194; TCGA KIRP -0.114; TCGA LGG -0.111; TCGA LIHC -0.112; TCGA LUAD -0.164; TCGA LUSC -0.421; TCGA OV -0.161; TCGA PRAD -0.067; TCGA STAD -0.227; TCGA UCEC -0.361 |
hsa-miR-331-5p | KIAA0408 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD | MirTarget; PITA | TCGA BLCA -1.29; TCGA BRCA -0.876; TCGA COAD -0.729; TCGA ESCA -1.111; TCGA HNSC -0.993; TCGA KIRC -0.428; TCGA LUAD -0.825; TCGA LUSC -0.897; TCGA PRAD -0.411; TCGA SARC -0.655; TCGA THCA -1.305; TCGA STAD -1.017 |
hsa-miR-331-5p | HSPA12A | 9 cancers: BLCA; BRCA; CESC; KIRC; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.46; TCGA BRCA -0.164; TCGA CESC -0.222; TCGA KIRC -0.193; TCGA LUAD -0.314; TCGA LUSC -0.472; TCGA PAAD -0.433; TCGA STAD -0.526; TCGA UCEC -0.189 |
hsa-miR-331-5p | RANBP3L | 12 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD | MirTarget | TCGA BLCA -1.313; TCGA BRCA -0.568; TCGA ESCA -0.859; TCGA KIRC -1.273; TCGA KIRP -0.736; TCGA LIHC -1.304; TCGA LUAD -0.547; TCGA LUSC -0.709; TCGA PAAD -0.395; TCGA PRAD -0.119; TCGA SARC -0.364; TCGA STAD -0.752 |
hsa-miR-331-5p | GPR155 | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; SARC; STAD | MirTarget; PITA | TCGA BLCA -0.349; TCGA BRCA -0.129; TCGA COAD -0.241; TCGA ESCA -0.489; TCGA HNSC -0.277; TCGA KIRC -0.164; TCGA LIHC -0.435; TCGA LUAD -0.154; TCGA LUSC -0.121; TCGA PAAD -0.267; TCGA SARC -0.278; TCGA STAD -0.587 |
hsa-miR-331-5p | SYNJ1 | 11 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; SARC; STAD; UCEC | MirTarget; PITA | TCGA BLCA -0.065; TCGA CESC -0.132; TCGA COAD -0.091; TCGA ESCA -0.128; TCGA KIRC -0.125; TCGA KIRP -0.113; TCGA LUAD -0.14; TCGA LUSC -0.212; TCGA SARC -0.086; TCGA STAD -0.083; TCGA UCEC -0.139 |
hsa-miR-331-5p | DNAJC27 | 10 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LIHC; LUAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.099; TCGA BRCA -0.084; TCGA CESC -0.147; TCGA COAD -0.076; TCGA KIRC -0.221; TCGA KIRP -0.201; TCGA LIHC -0.072; TCGA LUAD -0.093; TCGA STAD -0.255; TCGA UCEC -0.171 |
hsa-miR-331-5p | IL17D | 10 cancers: BLCA; BRCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.306; TCGA BRCA -0.335; TCGA HNSC -0.534; TCGA LGG -0.195; TCGA LUAD -0.217; TCGA LUSC -0.366; TCGA OV -0.177; TCGA PAAD -0.284; TCGA STAD -0.21; TCGA UCEC -0.28 |
hsa-miR-331-5p | FAM124B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.561; TCGA BRCA -0.334; TCGA CESC -0.59; TCGA COAD -0.541; TCGA ESCA -0.283; TCGA HNSC -0.414; TCGA LUAD -0.217; TCGA LUSC -0.554; TCGA PAAD -0.396; TCGA SARC -0.169; TCGA THCA -0.285; TCGA STAD -0.422; TCGA UCEC -0.497 |
hsa-miR-331-5p | SLAIN2 | 9 cancers: BLCA; KIRC; KIRP; LIHC; LUSC; PRAD; SARC; STAD; UCEC | MirTarget; PITA | TCGA BLCA -0.073; TCGA KIRC -0.062; TCGA KIRP -0.07; TCGA LIHC -0.107; TCGA LUSC -0.083; TCGA PRAD -0.053; TCGA SARC -0.098; TCGA STAD -0.172; TCGA UCEC -0.079 |
hsa-miR-331-5p | PCDHAC2 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.33; TCGA CESC -0.854; TCGA COAD -0.401; TCGA ESCA -0.745; TCGA HNSC -0.426; TCGA LUAD -0.223; TCGA LUSC -0.49; TCGA THCA -0.848; TCGA STAD -0.442; TCGA UCEC -0.3 |
hsa-miR-331-5p | KLRG1 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; SARC | MirTarget | TCGA BLCA -0.388; TCGA BRCA -0.135; TCGA CESC -0.356; TCGA COAD -0.205; TCGA ESCA -0.322; TCGA HNSC -0.451; TCGA LUAD -0.194; TCGA LUSC -0.617; TCGA PAAD -0.355; TCGA SARC -0.204 |
hsa-miR-331-5p | LEPROT | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.153; TCGA BRCA -0.125; TCGA COAD -0.202; TCGA ESCA -0.099; TCGA KIRC -0.279; TCGA LIHC -0.296; TCGA LUAD -0.112; TCGA LUSC -0.302; TCGA OV -0.112; TCGA STAD -0.235; TCGA UCEC -0.365 |
hsa-miR-331-5p | ADCY2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.957; TCGA BRCA -0.321; TCGA CESC -0.778; TCGA COAD -0.729; TCGA ESCA -0.694; TCGA HNSC -0.775; TCGA LGG -0.139; TCGA LUAD -0.415; TCGA SARC -0.87; TCGA STAD -0.974; TCGA UCEC -0.81 |
hsa-miR-331-5p | NUDT12 | 10 cancers: BLCA; CESC; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PRAD; UCEC | MirTarget | TCGA BLCA -0.127; TCGA CESC -0.212; TCGA HNSC -0.165; TCGA KIRC -0.185; TCGA LIHC -0.286; TCGA LUAD -0.187; TCGA LUSC -0.159; TCGA OV -0.122; TCGA PRAD -0.147; TCGA UCEC -0.177 |
hsa-miR-331-5p | PCDHA3 | 9 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LUAD; LUSC; UCEC | MirTarget | TCGA BLCA -0.501; TCGA BRCA -0.381; TCGA CESC -0.651; TCGA COAD -0.51; TCGA ESCA -0.494; TCGA KIRC -0.357; TCGA LUAD -0.367; TCGA LUSC -0.57; TCGA UCEC -0.803 |
hsa-miR-331-5p | ARRDC4 | 11 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; OV; STAD; UCEC | MirTarget | TCGA BLCA -0.317; TCGA BRCA -0.188; TCGA COAD -0.158; TCGA ESCA -0.309; TCGA KIRC -0.141; TCGA KIRP -0.231; TCGA LUAD -0.317; TCGA LUSC -0.26; TCGA OV -0.142; TCGA STAD -0.41; TCGA UCEC -0.336 |
hsa-miR-331-5p | PCDHA10 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; UCEC | MirTarget | TCGA BLCA -0.259; TCGA BRCA -0.478; TCGA CESC -0.775; TCGA COAD -0.651; TCGA ESCA -0.642; TCGA KIRC -0.346; TCGA KIRP -0.567; TCGA LUAD -0.353; TCGA LUSC -0.689; TCGA PAAD -0.476; TCGA UCEC -0.624 |
hsa-miR-331-5p | TMEM170B | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.188; TCGA CESC -0.283; TCGA COAD -0.194; TCGA ESCA -0.282; TCGA HNSC -0.359; TCGA LIHC -0.167; TCGA LUSC -0.297; TCGA STAD -0.348; TCGA UCEC -0.16 |
hsa-miR-331-5p | ECM2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.643; TCGA BRCA -0.431; TCGA CESC -0.469; TCGA COAD -0.618; TCGA ESCA -0.192; TCGA HNSC -0.384; TCGA KIRC -0.128; TCGA LIHC -0.767; TCGA LUAD -0.342; TCGA LUSC -0.796; TCGA OV -0.204; TCGA PAAD -0.328; TCGA STAD -0.428; TCGA UCEC -0.666 |
hsa-miR-331-5p | PDGFD | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.434; TCGA BRCA -0.444; TCGA CESC -0.505; TCGA COAD -0.46; TCGA ESCA -0.397; TCGA HNSC -0.586; TCGA KIRP -0.407; TCGA LUAD -0.293; TCGA LUSC -0.436; TCGA PAAD -0.274; TCGA STAD -0.431; TCGA UCEC -0.363 |
hsa-miR-331-5p | USP12 | 10 cancers: BLCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; OV; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.118; TCGA COAD -0.169; TCGA ESCA -0.125; TCGA KIRC -0.203; TCGA LIHC -0.182; TCGA LUAD -0.095; TCGA LUSC -0.204; TCGA OV -0.083; TCGA STAD -0.165; TCGA UCEC -0.204 |
hsa-miR-331-5p | TLR4 | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; UCEC | MirTarget | TCGA BLCA -0.336; TCGA BRCA -0.177; TCGA CESC -0.266; TCGA ESCA -0.417; TCGA HNSC -0.401; TCGA LIHC -0.135; TCGA LUAD -0.381; TCGA LUSC -0.727; TCGA PAAD -0.237; TCGA UCEC -0.286 |
hsa-miR-331-5p | ZNF704 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; LUSC; PAAD; STAD; UCEC | PITA; mirMAP; miRNATAP | TCGA BLCA -0.236; TCGA BRCA -0.167; TCGA CESC -0.449; TCGA COAD -0.307; TCGA HNSC -0.418; TCGA KIRC -0.397; TCGA LUSC -0.237; TCGA PAAD -0.233; TCGA STAD -0.338; TCGA UCEC -0.184 |
hsa-miR-331-5p | DAB2 | 10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; UCEC | PITA | TCGA BLCA -0.298; TCGA BRCA -0.21; TCGA CESC -0.196; TCGA COAD -0.236; TCGA HNSC -0.422; TCGA LGG -0.112; TCGA LUAD -0.276; TCGA LUSC -0.577; TCGA PAAD -0.218; TCGA UCEC -0.338 |
hsa-miR-331-5p | MEF2C | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC | PITA | TCGA BLCA -0.532; TCGA BRCA -0.221; TCGA CESC -0.352; TCGA COAD -0.455; TCGA ESCA -0.287; TCGA HNSC -0.544; TCGA LIHC -0.086; TCGA LUAD -0.333; TCGA LUSC -0.586; TCGA OV -0.124; TCGA PAAD -0.284; TCGA SARC -0.165; TCGA STAD -0.425; TCGA UCEC -0.497 |
hsa-miR-331-5p | PAPPA | 9 cancers: BLCA; BRCA; COAD; KIRC; LGG; LUSC; THCA; STAD; UCEC | PITA | TCGA BLCA -0.295; TCGA BRCA -0.278; TCGA COAD -0.345; TCGA KIRC -0.656; TCGA LGG -0.18; TCGA LUSC -0.505; TCGA THCA -0.567; TCGA STAD -0.251; TCGA UCEC -0.856 |
hsa-miR-331-5p | DUSP1 | 9 cancers: BLCA; BRCA; ESCA; HNSC; LIHC; LUAD; LUSC; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.673; TCGA BRCA -0.469; TCGA ESCA -0.298; TCGA HNSC -0.406; TCGA LIHC -0.29; TCGA LUAD -0.345; TCGA LUSC -0.589; TCGA STAD -0.467; TCGA UCEC -0.605 |
hsa-miR-331-5p | AKAP12 | 9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUSC; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.483; TCGA BRCA -0.517; TCGA COAD -0.724; TCGA ESCA -0.412; TCGA HNSC -0.457; TCGA LIHC -0.266; TCGA LUSC -0.729; TCGA STAD -0.754; TCGA UCEC -0.345 |
hsa-miR-331-5p | RNF103 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; SARC; STAD; UCEC | PITA | TCGA BLCA -0.059; TCGA CESC -0.154; TCGA COAD -0.106; TCGA ESCA -0.223; TCGA HNSC -0.072; TCGA LIHC -0.074; TCGA LUSC -0.064; TCGA SARC -0.099; TCGA STAD -0.116; TCGA UCEC -0.143 |
hsa-miR-331-5p | RUSC2 | 11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; STAD; UCEC | PITA | TCGA BLCA -0.371; TCGA BRCA -0.174; TCGA COAD -0.209; TCGA ESCA -0.203; TCGA HNSC -0.23; TCGA KIRC -0.096; TCGA LUAD -0.084; TCGA LUSC -0.275; TCGA SARC -0.169; TCGA STAD -0.337; TCGA UCEC -0.304 |
hsa-miR-331-5p | PCDH9 | 11 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; STAD | PITA | TCGA BLCA -0.508; TCGA BRCA -0.328; TCGA CESC -0.42; TCGA COAD -0.758; TCGA HNSC -0.412; TCGA KIRC -0.813; TCGA KIRP -0.422; TCGA LUAD -0.343; TCGA LUSC -0.555; TCGA PAAD -0.364; TCGA STAD -1.14 |
hsa-miR-331-5p | PHYHIPL | 10 cancers: BLCA; BRCA; COAD; HNSC; LGG; LIHC; LUSC; PAAD; SARC; STAD | PITA; miRNATAP | TCGA BLCA -0.492; TCGA BRCA -0.502; TCGA COAD -0.458; TCGA HNSC -0.356; TCGA LGG -0.328; TCGA LIHC -0.367; TCGA LUSC -0.622; TCGA PAAD -0.383; TCGA SARC -0.391; TCGA STAD -0.723 |
hsa-miR-331-5p | STARD13 | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | PITA | TCGA BLCA -0.535; TCGA BRCA -0.215; TCGA CESC -0.277; TCGA COAD -0.18; TCGA ESCA -0.335; TCGA LIHC -0.328; TCGA LUAD -0.226; TCGA LUSC -0.643; TCGA OV -0.15; TCGA PAAD -0.176; TCGA STAD -0.422; TCGA UCEC -0.343 |
hsa-miR-331-5p | ANTXR2 | 10 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; PRAD; STAD; UCEC | PITA; miRNATAP | TCGA BLCA -0.561; TCGA BRCA -0.224; TCGA COAD -0.199; TCGA ESCA -0.341; TCGA LIHC -0.15; TCGA LUAD -0.1; TCGA LUSC -0.459; TCGA PRAD -0.136; TCGA STAD -0.494; TCGA UCEC -0.556 |
hsa-miR-331-5p | SPATA6 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; STAD; UCEC | mirMAP | TCGA BLCA -0.215; TCGA BRCA -0.108; TCGA CESC -0.814; TCGA ESCA -0.374; TCGA HNSC -0.287; TCGA KIRC -0.265; TCGA KIRP -0.239; TCGA LUAD -0.192; TCGA LUSC -0.407; TCGA STAD -0.319; TCGA UCEC -0.177 |
hsa-miR-331-5p | NTRK3 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -1.052; TCGA BRCA -0.46; TCGA CESC -0.964; TCGA COAD -0.971; TCGA ESCA -0.972; TCGA HNSC -0.762; TCGA KIRC -0.418; TCGA LUAD -0.541; TCGA LUSC -0.956; TCGA PRAD -0.205; TCGA SARC -0.455; TCGA THCA -0.594; TCGA STAD -0.909; TCGA UCEC -0.682 |
hsa-miR-331-5p | PDE1C | 12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -1.004; TCGA BRCA -0.7; TCGA COAD -0.418; TCGA ESCA -0.79; TCGA HNSC -0.355; TCGA KIRC -0.388; TCGA LUSC -0.829; TCGA PRAD -0.222; TCGA SARC -0.53; TCGA THCA -0.663; TCGA STAD -0.818; TCGA UCEC -0.456 |
hsa-miR-331-5p | PTCHD1 | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUAD; LUSC; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.748; TCGA BRCA -0.411; TCGA CESC -0.398; TCGA COAD -0.753; TCGA ESCA -0.434; TCGA LUAD -0.432; TCGA LUSC -0.355; TCGA SARC -1.008; TCGA STAD -1.392; TCGA UCEC -0.938 |
hsa-miR-331-5p | SGCD | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; STAD; UCEC | mirMAP | TCGA BLCA -1.108; TCGA BRCA -0.39; TCGA CESC -0.581; TCGA COAD -0.785; TCGA ESCA -0.571; TCGA HNSC -0.686; TCGA LUAD -0.43; TCGA LUSC -0.777; TCGA OV -0.285; TCGA STAD -0.766; TCGA UCEC -0.592 |
hsa-miR-331-5p | STMN2 | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; THCA; STAD | miRNATAP | TCGA BLCA -0.526; TCGA BRCA -0.266; TCGA CESC -0.388; TCGA COAD -1.143; TCGA ESCA -0.841; TCGA HNSC -0.536; TCGA LUSC -0.39; TCGA OV -0.335; TCGA PAAD -0.532; TCGA THCA -1.27; TCGA STAD -1.118 |
hsa-miR-331-5p | SASH1 | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.219; TCGA BRCA -0.288; TCGA CESC -0.308; TCGA COAD -0.121; TCGA ESCA -0.286; TCGA HNSC -0.479; TCGA KIRC -0.127; TCGA LIHC -0.124; TCGA LUAD -0.165; TCGA LUSC -0.358; TCGA PAAD -0.199; TCGA STAD -0.352; TCGA UCEC -0.29 |
hsa-miR-331-5p | CYR61 | 10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LIHC; LUAD; LUSC; STAD; UCEC | miRNATAP | TCGA BLCA -0.67; TCGA BRCA -0.414; TCGA COAD -0.304; TCGA HNSC -0.326; TCGA KIRC -0.271; TCGA LIHC -0.336; TCGA LUAD -0.208; TCGA LUSC -0.588; TCGA STAD -0.275; TCGA UCEC -0.421 |
hsa-miR-331-5p | HLF | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -1; TCGA BRCA -0.635; TCGA COAD -0.357; TCGA HNSC -0.48; TCGA KIRC -0.303; TCGA KIRP -0.188; TCGA LIHC -0.88; TCGA LUAD -0.569; TCGA PRAD -0.127; TCGA SARC -0.305; TCGA STAD -1.077; TCGA UCEC -0.888 |
hsa-miR-331-5p | VGLL3 | 9 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.281; TCGA BRCA -0.254; TCGA COAD -0.607; TCGA HNSC -0.311; TCGA LUAD -0.286; TCGA LUSC -0.939; TCGA SARC -0.389; TCGA STAD -0.273; TCGA UCEC -0.639 |
hsa-miR-331-5p | TGFB2 | 9 cancers: BLCA; BRCA; COAD; KIRC; LUSC; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.24; TCGA BRCA -0.257; TCGA COAD -0.39; TCGA KIRC -0.235; TCGA LUSC -0.591; TCGA PRAD -0.126; TCGA THCA -0.373; TCGA STAD -0.181; TCGA UCEC -0.38 |
hsa-miR-331-5p | SH3BGRL2 | 11 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUSC; PRAD; STAD; UCEC | miRNATAP | TCGA BLCA -0.126; TCGA BRCA -0.304; TCGA CESC -0.639; TCGA ESCA -0.594; TCGA HNSC -0.754; TCGA KIRC -0.226; TCGA LIHC -0.295; TCGA LUSC -0.25; TCGA PRAD -0.149; TCGA STAD -0.17; TCGA UCEC -0.141 |
hsa-miR-331-5p | TRHDE | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; STAD; UCEC | MirTarget | TCGA BRCA -0.719; TCGA CESC -0.942; TCGA ESCA -0.622; TCGA HNSC -0.559; TCGA KIRC -0.594; TCGA KIRP -0.43; TCGA LUAD -0.475; TCGA LUSC -0.9; TCGA PRAD -0.199; TCGA STAD -0.471; TCGA UCEC -0.786 |
hsa-miR-331-5p | EPHA4 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; SARC; THCA; STAD; UCEC | PITA; miRNATAP | TCGA BRCA -0.184; TCGA HNSC -0.235; TCGA KIRC -0.341; TCGA KIRP -0.469; TCGA LIHC -0.194; TCGA SARC -0.203; TCGA THCA -0.385; TCGA STAD -0.411; TCGA UCEC -0.515 |
hsa-miR-331-5p | BHLHE41 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.367; TCGA CESC -0.486; TCGA COAD -0.251; TCGA ESCA -0.299; TCGA HNSC -0.435; TCGA LUAD -0.322; TCGA LUSC -0.723; TCGA PRAD -0.104; TCGA THCA -0.396; TCGA STAD -0.213; TCGA UCEC -0.21 |
hsa-miR-331-5p | PCBD2 | 9 cancers: CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; OV; STAD | MirTarget | TCGA CESC -0.142; TCGA ESCA -0.133; TCGA HNSC -0.138; TCGA KIRP -0.089; TCGA LGG -0.142; TCGA LIHC -0.105; TCGA LUAD -0.098; TCGA OV -0.089; TCGA STAD -0.141 |
hsa-miR-331-5p | CRBN | 13 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA CESC -0.096; TCGA COAD -0.082; TCGA ESCA -0.211; TCGA HNSC -0.167; TCGA KIRC -0.175; TCGA KIRP -0.084; TCGA LIHC -0.181; TCGA LUAD -0.113; TCGA LUSC -0.161; TCGA OV -0.085; TCGA SARC -0.149; TCGA STAD -0.206; TCGA UCEC -0.204 |
Enriched cancer pathways of putative targets